Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "peritoneal cavity osmotic gradient" is a physiological phenomenon central to peritoneal dialysis (PD). It refers to the difference in osmotic pressure across the peritoneal membrane, typically created by instilling hypertonic dialysis solutions (most commonly glucose-based) into the peritoneal cavity. This gradient drives water movement from blood capillaries into the peritoneal space, enabling ultrafiltration and solute clearance in patients with kidney failure. Loss of this gradient effectiveness can lead to reduced ultrafiltration ('UF failure').
Hyperosmolar solutions create an osmotic gradient across the peritoneal membrane, driving water and solute movement from the blood into the peritoneal cavity for removal.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peritoneal Cavity Osmotic Gradient.